Middle East & Africa Veterinary Vaccines Market Size and Forecast (2021 - 2031)
The Middle East & Africa Veterinary Vaccines Market is projected to grow significantly, reaching an estimated US$ 486.1 million by 2031, up from US$ 365.2 million in 2024. This growth represents a compound annual growth rate (CAGR) of 4.2% from 2025 to 2031, indicating a stable upward trend in the market.
Executive Summary and Market Analysis
The veterinary vaccines market in the Middle East and Africa encompasses key regions including Saudi Arabia, the United Arab Emirates (UAE), South Africa, and other areas within the region. The anticipated growth is primarily driven by the rising incidence of livestock diseases and proactive government initiatives aimed at enhancing animal health management. Saudi Arabia stands out as the largest market in the region, bolstered by advancements in its livestock sector and substantial investments in veterinary research and vaccine production.
Governments across the region are increasingly focusing on food security and animal welfare, leading to heightened capital investments and policy spending on vaccination systems. Additionally, there is a growing awareness among farmers and pet owners regarding preventive health measures and the importance of animal immunity, which is further driving vaccine uptake. South Africa and the UAE are emerging as significant markets as well, benefiting from improvements in veterinary healthcare infrastructure and technological advancements. Overall, government support and the rising demand for livestock health are expected to positively influence market trends throughout the region.
Strategic Insights
Market Segmentation Analysis
The Middle East & Africa Veterinary Vaccines Market can be segmented based on various criteria:
Technological innovations are playing a crucial role in transforming the veterinary vaccine landscape, enhancing vaccine development, delivery, and overall effectiveness. New technologies such as recombinant DNA technology, vector-based vaccines, and mRNA platforms are revolutionizing the field, providing protection against chronic and life-threatening diseases. For instance, recombinant vaccines like the Merial PUREVAX series for cats eliminate the need for live pathogens while still offering robust immunity, thereby reducing the risk of adverse reactions.
The recent prominence of mRNA technology is also being explored for veterinary applications, with companies like Elanco investing in research to develop next-generation animal vaccines. Innovations in vaccine delivery methods, including oral vaccines and needle-free injectors, are improving convenience and compliance among pet owners and livestock producers. An example of this is the oral rabies vaccine developed by Boehringer Ingelheim, which has been widely used in wildlife management initiatives, showcasing the potential for new delivery methods in the market.
Country Insights
The market is further segmented by country, with South Africa, Saudi Arabia, the UAE, and the Rest of the Middle East & Africa being key players. South Africa held the largest market share in 2024, driven by the presence of numerous national and international organizations dedicated to promoting animal health. The continent's vast population of livestock and companion animals necessitates effective animal healthcare management, supported by organizations such as The South African Animal Health Association and the World Organization for Animal Health.
In May 2023, the Vaccination Guidelines Group (VGG) of the World Small Animal Veterinary Association (WSAVA) initiated a project aimed at enhancing awareness of infectious diseases and the importance of vaccinating dogs and cats across Sub-Saharan Africa. This initiative also provides guidance to veterinarians on best vaccination practices.
Moreover, in June 2024, Gavi launched the African Vaccine Manufacturing Accelerator (AVMA), a funding initiative that aims to invest up to US$ 1.2 billion over the next decade to support the sustainable development of Africa's vaccine manufacturing sector.
Company Profiles
Key players in the Middle East & Africa Veterinary Vaccines Market include Merck & Co. Inc., Boehringer Ingelheim International GmbH, Ceva Sant? Animale, Zoetis Inc., Elanco Animal Health Inc., Virbac SA, Neogen Corp, Hester Biosciences Ltd, HIPRA SA, and Biovac LTD. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their product offerings and increase market share.
Executive Summary and Market Analysis
The veterinary vaccines market in the Middle East and Africa encompasses key regions including Saudi Arabia, the United Arab Emirates (UAE), South Africa, and other areas within the region. The anticipated growth is primarily driven by the rising incidence of livestock diseases and proactive government initiatives aimed at enhancing animal health management. Saudi Arabia stands out as the largest market in the region, bolstered by advancements in its livestock sector and substantial investments in veterinary research and vaccine production.
Governments across the region are increasingly focusing on food security and animal welfare, leading to heightened capital investments and policy spending on vaccination systems. Additionally, there is a growing awareness among farmers and pet owners regarding preventive health measures and the importance of animal immunity, which is further driving vaccine uptake. South Africa and the UAE are emerging as significant markets as well, benefiting from improvements in veterinary healthcare infrastructure and technological advancements. Overall, government support and the rising demand for livestock health are expected to positively influence market trends throughout the region.
Strategic Insights
Market Segmentation Analysis
The Middle East & Africa Veterinary Vaccines Market can be segmented based on various criteria:
- By Technology: The market is divided into Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, Toxoid Vaccines, and Others. In 2024, Live Attenuated Vaccines held the largest market share.
- By Animal Type: The market is categorized into Companion Animals and Livestock & Poultry, with Livestock and Poultry dominating the market share in 2024.
- By Companion Animal: This segment includes Dogs, Cats, Horses, and Others, where Dogs accounted for the largest share in 2024.
- By Livestock and Poultry: This includes Chicken, Cattle, and Others, with Chicken leading the market share in 2024.
- By Route of Administration: The market is segmented into Intramuscular, Subcutaneous, and Others, with Intramuscular administration holding the largest share in 2024.
- By End User: This includes Veterinary Hospitals, Veterinary Clinics, and Others, where Veterinary Hospitals had the largest market share in 2024.
Technological innovations are playing a crucial role in transforming the veterinary vaccine landscape, enhancing vaccine development, delivery, and overall effectiveness. New technologies such as recombinant DNA technology, vector-based vaccines, and mRNA platforms are revolutionizing the field, providing protection against chronic and life-threatening diseases. For instance, recombinant vaccines like the Merial PUREVAX series for cats eliminate the need for live pathogens while still offering robust immunity, thereby reducing the risk of adverse reactions.
The recent prominence of mRNA technology is also being explored for veterinary applications, with companies like Elanco investing in research to develop next-generation animal vaccines. Innovations in vaccine delivery methods, including oral vaccines and needle-free injectors, are improving convenience and compliance among pet owners and livestock producers. An example of this is the oral rabies vaccine developed by Boehringer Ingelheim, which has been widely used in wildlife management initiatives, showcasing the potential for new delivery methods in the market.
Country Insights
The market is further segmented by country, with South Africa, Saudi Arabia, the UAE, and the Rest of the Middle East & Africa being key players. South Africa held the largest market share in 2024, driven by the presence of numerous national and international organizations dedicated to promoting animal health. The continent's vast population of livestock and companion animals necessitates effective animal healthcare management, supported by organizations such as The South African Animal Health Association and the World Organization for Animal Health.
In May 2023, the Vaccination Guidelines Group (VGG) of the World Small Animal Veterinary Association (WSAVA) initiated a project aimed at enhancing awareness of infectious diseases and the importance of vaccinating dogs and cats across Sub-Saharan Africa. This initiative also provides guidance to veterinarians on best vaccination practices.
Moreover, in June 2024, Gavi launched the African Vaccine Manufacturing Accelerator (AVMA), a funding initiative that aims to invest up to US$ 1.2 billion over the next decade to support the sustainable development of Africa's vaccine manufacturing sector.
Company Profiles
Key players in the Middle East & Africa Veterinary Vaccines Market include Merck & Co. Inc., Boehringer Ingelheim International GmbH, Ceva Sant? Animale, Zoetis Inc., Elanco Animal Health Inc., Virbac SA, Neogen Corp, Hester Biosciences Ltd, HIPRA SA, and Biovac LTD. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their product offerings and increase market share.
1. INTRODUCTION
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. VETERINARY VACCINES MARKET LANDSCAPE
4.1 Market Overview
4.2 PEST Analysis
5. MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. VETERINARY VACCINES MARKET - MIDDLE EAST & AFRICA MARKET ANALYSIS
6.1 Middle East & Africa Veterinary Vaccines Market Revenue (US$ Million), 2024 - 2031
6.2 Middle East & Africa Veterinary Vaccines Market Forecast and Analysis
7. MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET REVENUE ANALYSIS - BY TECHNOLOGY
7.1 Live Attenuated Vaccines
7.1.1 Overview
7.1.2 Live Attenuated Vaccines: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Inactivated Vaccines
7.2.1 Overview
7.2.2 Inactivated Vaccines: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Recombinant Vaccines
7.3.1 Overview
7.3.2 Recombinant Vaccines: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Toxoid Vaccines
7.4.1 Overview
7.4.2 Toxoid Vaccines: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET REVENUE ANALYSIS - BY ANIMAL TYPE
8.1 Companion
8.1.1 Overview
8.1.2 Companion: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Livestock and Poultry
8.2.1 Overview
8.2.2 Livestock and Poultry: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET REVENUE ANALYSIS - BY COMPANION
9.1 Dogs
9.1.1 Overview
9.1.2 Dogs: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Cat
9.2.1 Overview
9.2.2 Cat: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Horses
9.3.1 Overview
9.3.2 Horses: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.4 Others
9.4.1 Overview
9.4.2 Others: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET REVENUE ANALYSIS - BY LIVESTOCK AND POULTRY
10.1 Chicken
10.1.1 Overview
10.1.2 Chicken: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 Cattle
10.2.1 Overview
10.2.2 Cattle: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Others
10.3.1 Overview
10.3.2 Others: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET REVENUE ANALYSIS - BY ROUTE OF ADMINISTRATION
11.1 Intramuscular
11.1.1 Overview
11.1.2 Intramuscular: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2 Subcutaneous
11.2.1 Overview
11.2.2 Subcutaneous: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.3 Others
11.3.1 Overview
11.3.2 Others: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12. MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET REVENUE ANALYSIS - BY END USER
12.1 Veterinary Hospitals
12.1.1 Overview
12.1.2 Veterinary Hospitals: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.2 Veterinary Clinics
12.2.1 Overview
12.2.2 Veterinary Clinics: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.3 Others
12.3.1 Overview
12.3.2 Others: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13. MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET - COUNTRY ANALYSIS
13.1 Middle East & Africa
13.1.1 Middle East & Africa Veterinary Vaccines Market Revenue and Forecast and Analysis - by Country
13.1.1.1 Middle East & Africa Veterinary Vaccines Market Revenue and Forecast and Analysis - by Country
13.1.2.2 South Africa: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.1.2.2.1 South Africa: Middle East & Africa Veterinary Vaccines Market Share - by Technology
13.1.2.2.2 South Africa: Middle East & Africa Veterinary Vaccines Market Share - by Animal Type
13.1.2.2.3 South Africa: Middle East & Africa Veterinary Vaccines Market Share - by Companion
13.1.2.2.4 South Africa: Middle East & Africa Veterinary Vaccines Market Share - by Livestock And Poultry
13.1.2.2.5 South Africa: Middle East & Africa Veterinary Vaccines Market Share - by Route Of Administration
13.1.2.2.6 South Africa: Middle East & Africa Veterinary Vaccines Market Share - by End User
13.2.3.3 Saudi Arabia: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.2.3.3.1 Saudi Arabia: Middle East & Africa Veterinary Vaccines Market Share - by Technology
13.2.3.3.2 Saudi Arabia: Middle East & Africa Veterinary Vaccines Market Share - by Animal Type
13.2.3.3.3 Saudi Arabia: Middle East & Africa Veterinary Vaccines Market Share - by Companion
13.2.3.3.4 Saudi Arabia: Middle East & Africa Veterinary Vaccines Market Share - by Livestock And Poultry
13.2.3.3.5 Saudi Arabia: Middle East & Africa Veterinary Vaccines Market Share - by Route Of Administration
13.2.3.3.6 Saudi Arabia: Middle East & Africa Veterinary Vaccines Market Share - by End User
13.3.4.4 United Arab Emirates: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.3.4.4.1 United Arab Emirates: Middle East & Africa Veterinary Vaccines Market Share - by Technology
13.3.4.4.2 United Arab Emirates: Middle East & Africa Veterinary Vaccines Market Share - by Animal Type
13.3.4.4.3 United Arab Emirates: Middle East & Africa Veterinary Vaccines Market Share - by Companion
13.3.4.4.4 United Arab Emirates: Middle East & Africa Veterinary Vaccines Market Share - by Livestock And Poultry
13.3.4.4.5 United Arab Emirates: Middle East & Africa Veterinary Vaccines Market Share - by Route Of Administration
13.3.4.4.6 United Arab Emirates: Middle East & Africa Veterinary Vaccines Market Share - by End User
13.4.5.5 Rest of Middle East & Africa: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.4.5.5.1 Rest of Middle East & Africa: Middle East & Africa Veterinary Vaccines Market Share - by Technology
13.4.5.5.2 Rest of Middle East & Africa: Middle East & Africa Veterinary Vaccines Market Share - by Animal Type
13.4.5.5.3 Rest of Middle East & Africa: Middle East & Africa Veterinary Vaccines Market Share - by Companion
13.4.5.5.4 Rest of Middle East & Africa: Middle East & Africa Veterinary Vaccines Market Share - by Livestock And Poultry
13.4.5.5.5 Rest of Middle East & Africa: Middle East & Africa Veterinary Vaccines Market Share - by Route Of Administration
13.4.5.5.6 Rest of Middle East & Africa: Middle East & Africa Veterinary Vaccines Market Share - by End User
15 INDUSTRY LANDSCAPE
15.1 Overview
15.2 New Product Development
15.3 Merger and Acquisition
15.4 Other Strategic Developments
16 COMPANY PROFILES
16.1 Merck & Co Inc
16.1.1 Key Facts
16.1.2 Business Description
16.1.3 Products and Services
16.1.4 Financial Overview
16.1.5 SWOT Analysis
16.1.6 Key Developments
16.2 Boehringer Ingelheim International GmbH
16.2.1 Key Facts
16.2.2 Business Description
16.2.3 Products and Services
16.2.4 Financial Overview
16.2.5 SWOT Analysis
16.2.6 Key Developments
16.3 Ceva Sane Animale
16.3.1 Key Facts
16.3.2 Business Description
16.3.3 Products and Services
16.3.4 Financial Overview
16.3.5 SWOT Analysis
16.3.6 Key Developments
16.4 Zoetis Inc
16.4.1 Key Facts
16.4.2 Business Description
16.4.3 Products and Services
16.4.4 Financial Overview
16.4.5 SWOT Analysis
16.4.6 Key Developments
16.5 Elanco Animal Health Inc
16.5.1 Key Facts
16.5.2 Business Description
16.5.3 Products and Services
16.5.4 Financial Overview
16.5.5 SWOT Analysis
16.5.6 Key Developments
16.6 Virbac SA
16.6.1 Key Facts
16.6.2 Business Description
16.6.3 Products and Services
16.6.4 Financial Overview
16.6.5 SWOT Analysis
16.6.6 Key Developments
16.7 Neogen Corp
16.7.1 Key Facts
16.7.2 Business Description
16.7.3 Products and Services
16.7.4 Financial Overview
16.7.5 SWOT Analysis
16.7.6 Key Developments
16.8 Hester Biosciences Ltd
16.8.1 Key Facts
16.8.2 Business Description
16.8.3 Products and Services
16.8.4 Financial Overview
16.8.5 SWOT Analysis
16.8.6 Key Developments
16.9 HIPRA SA
16.9.1 Key Facts
16.9.2 Business Description
16.9.3 Products and Services
16.9.4 Financial Overview
16.9.5 SWOT Analysis
16.9.6 Key Developments
16.10 Biovac LTD
16.10.1 Key Facts
16.10.2 Business Description
16.10.3 Products and Services
16.10.4 Financial Overview
16.10.5 SWOT Analysis
16.10.6 Key Developments
17. APPENDIX
17.1 About The Insight Partners
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. VETERINARY VACCINES MARKET LANDSCAPE
4.1 Market Overview
4.2 PEST Analysis
5. MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. VETERINARY VACCINES MARKET - MIDDLE EAST & AFRICA MARKET ANALYSIS
6.1 Middle East & Africa Veterinary Vaccines Market Revenue (US$ Million), 2024 - 2031
6.2 Middle East & Africa Veterinary Vaccines Market Forecast and Analysis
7. MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET REVENUE ANALYSIS - BY TECHNOLOGY
7.1 Live Attenuated Vaccines
7.1.1 Overview
7.1.2 Live Attenuated Vaccines: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Inactivated Vaccines
7.2.1 Overview
7.2.2 Inactivated Vaccines: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Recombinant Vaccines
7.3.1 Overview
7.3.2 Recombinant Vaccines: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Toxoid Vaccines
7.4.1 Overview
7.4.2 Toxoid Vaccines: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET REVENUE ANALYSIS - BY ANIMAL TYPE
8.1 Companion
8.1.1 Overview
8.1.2 Companion: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Livestock and Poultry
8.2.1 Overview
8.2.2 Livestock and Poultry: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET REVENUE ANALYSIS - BY COMPANION
9.1 Dogs
9.1.1 Overview
9.1.2 Dogs: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Cat
9.2.1 Overview
9.2.2 Cat: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Horses
9.3.1 Overview
9.3.2 Horses: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.4 Others
9.4.1 Overview
9.4.2 Others: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET REVENUE ANALYSIS - BY LIVESTOCK AND POULTRY
10.1 Chicken
10.1.1 Overview
10.1.2 Chicken: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 Cattle
10.2.1 Overview
10.2.2 Cattle: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Others
10.3.1 Overview
10.3.2 Others: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET REVENUE ANALYSIS - BY ROUTE OF ADMINISTRATION
11.1 Intramuscular
11.1.1 Overview
11.1.2 Intramuscular: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2 Subcutaneous
11.2.1 Overview
11.2.2 Subcutaneous: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.3 Others
11.3.1 Overview
11.3.2 Others: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12. MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET REVENUE ANALYSIS - BY END USER
12.1 Veterinary Hospitals
12.1.1 Overview
12.1.2 Veterinary Hospitals: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.2 Veterinary Clinics
12.2.1 Overview
12.2.2 Veterinary Clinics: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.3 Others
12.3.1 Overview
12.3.2 Others: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13. MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET - COUNTRY ANALYSIS
13.1 Middle East & Africa
13.1.1 Middle East & Africa Veterinary Vaccines Market Revenue and Forecast and Analysis - by Country
13.1.1.1 Middle East & Africa Veterinary Vaccines Market Revenue and Forecast and Analysis - by Country
13.1.2.2 South Africa: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.1.2.2.1 South Africa: Middle East & Africa Veterinary Vaccines Market Share - by Technology
13.1.2.2.2 South Africa: Middle East & Africa Veterinary Vaccines Market Share - by Animal Type
13.1.2.2.3 South Africa: Middle East & Africa Veterinary Vaccines Market Share - by Companion
13.1.2.2.4 South Africa: Middle East & Africa Veterinary Vaccines Market Share - by Livestock And Poultry
13.1.2.2.5 South Africa: Middle East & Africa Veterinary Vaccines Market Share - by Route Of Administration
13.1.2.2.6 South Africa: Middle East & Africa Veterinary Vaccines Market Share - by End User
13.2.3.3 Saudi Arabia: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.2.3.3.1 Saudi Arabia: Middle East & Africa Veterinary Vaccines Market Share - by Technology
13.2.3.3.2 Saudi Arabia: Middle East & Africa Veterinary Vaccines Market Share - by Animal Type
13.2.3.3.3 Saudi Arabia: Middle East & Africa Veterinary Vaccines Market Share - by Companion
13.2.3.3.4 Saudi Arabia: Middle East & Africa Veterinary Vaccines Market Share - by Livestock And Poultry
13.2.3.3.5 Saudi Arabia: Middle East & Africa Veterinary Vaccines Market Share - by Route Of Administration
13.2.3.3.6 Saudi Arabia: Middle East & Africa Veterinary Vaccines Market Share - by End User
13.3.4.4 United Arab Emirates: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.3.4.4.1 United Arab Emirates: Middle East & Africa Veterinary Vaccines Market Share - by Technology
13.3.4.4.2 United Arab Emirates: Middle East & Africa Veterinary Vaccines Market Share - by Animal Type
13.3.4.4.3 United Arab Emirates: Middle East & Africa Veterinary Vaccines Market Share - by Companion
13.3.4.4.4 United Arab Emirates: Middle East & Africa Veterinary Vaccines Market Share - by Livestock And Poultry
13.3.4.4.5 United Arab Emirates: Middle East & Africa Veterinary Vaccines Market Share - by Route Of Administration
13.3.4.4.6 United Arab Emirates: Middle East & Africa Veterinary Vaccines Market Share - by End User
13.4.5.5 Rest of Middle East & Africa: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.4.5.5.1 Rest of Middle East & Africa: Middle East & Africa Veterinary Vaccines Market Share - by Technology
13.4.5.5.2 Rest of Middle East & Africa: Middle East & Africa Veterinary Vaccines Market Share - by Animal Type
13.4.5.5.3 Rest of Middle East & Africa: Middle East & Africa Veterinary Vaccines Market Share - by Companion
13.4.5.5.4 Rest of Middle East & Africa: Middle East & Africa Veterinary Vaccines Market Share - by Livestock And Poultry
13.4.5.5.5 Rest of Middle East & Africa: Middle East & Africa Veterinary Vaccines Market Share - by Route Of Administration
13.4.5.5.6 Rest of Middle East & Africa: Middle East & Africa Veterinary Vaccines Market Share - by End User
15 INDUSTRY LANDSCAPE
15.1 Overview
15.2 New Product Development
15.3 Merger and Acquisition
15.4 Other Strategic Developments
16 COMPANY PROFILES
16.1 Merck & Co Inc
16.1.1 Key Facts
16.1.2 Business Description
16.1.3 Products and Services
16.1.4 Financial Overview
16.1.5 SWOT Analysis
16.1.6 Key Developments
16.2 Boehringer Ingelheim International GmbH
16.2.1 Key Facts
16.2.2 Business Description
16.2.3 Products and Services
16.2.4 Financial Overview
16.2.5 SWOT Analysis
16.2.6 Key Developments
16.3 Ceva Sane Animale
16.3.1 Key Facts
16.3.2 Business Description
16.3.3 Products and Services
16.3.4 Financial Overview
16.3.5 SWOT Analysis
16.3.6 Key Developments
16.4 Zoetis Inc
16.4.1 Key Facts
16.4.2 Business Description
16.4.3 Products and Services
16.4.4 Financial Overview
16.4.5 SWOT Analysis
16.4.6 Key Developments
16.5 Elanco Animal Health Inc
16.5.1 Key Facts
16.5.2 Business Description
16.5.3 Products and Services
16.5.4 Financial Overview
16.5.5 SWOT Analysis
16.5.6 Key Developments
16.6 Virbac SA
16.6.1 Key Facts
16.6.2 Business Description
16.6.3 Products and Services
16.6.4 Financial Overview
16.6.5 SWOT Analysis
16.6.6 Key Developments
16.7 Neogen Corp
16.7.1 Key Facts
16.7.2 Business Description
16.7.3 Products and Services
16.7.4 Financial Overview
16.7.5 SWOT Analysis
16.7.6 Key Developments
16.8 Hester Biosciences Ltd
16.8.1 Key Facts
16.8.2 Business Description
16.8.3 Products and Services
16.8.4 Financial Overview
16.8.5 SWOT Analysis
16.8.6 Key Developments
16.9 HIPRA SA
16.9.1 Key Facts
16.9.2 Business Description
16.9.3 Products and Services
16.9.4 Financial Overview
16.9.5 SWOT Analysis
16.9.6 Key Developments
16.10 Biovac LTD
16.10.1 Key Facts
16.10.2 Business Description
16.10.3 Products and Services
16.10.4 Financial Overview
16.10.5 SWOT Analysis
16.10.6 Key Developments
17. APPENDIX
17.1 About The Insight Partners
LIST OF TABLES
Table 1. Middle East & Africa Veterinary Vaccines Market Segmentation
Table 3. Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 5. Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 6. Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 7. Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 8. Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 9. Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 10. Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 11. South Africa: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 12. South Africa: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 13. South Africa: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 14. South Africa: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 15. South Africa: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 16. South Africa: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 17. Saudi Arabia: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 18. Saudi Arabia: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 19. Saudi Arabia: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 20. Saudi Arabia: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 21. Saudi Arabia: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 22. Saudi Arabia: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 23. United Arab Emirates: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 24. United Arab Emirates: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 25. United Arab Emirates: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 26. United Arab Emirates: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 27. United Arab Emirates: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 28. United Arab Emirates: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 29. Rest of Middle East & Africa: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 30. Rest of Middle East & Africa: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 31. Rest of Middle East & Africa: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 32. Rest of Middle East & Africa: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 33. Rest of Middle East & Africa: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 34. Rest of Middle East & Africa: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 1. Middle East & Africa Veterinary Vaccines Market Segmentation
Table 3. Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 5. Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 6. Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 7. Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 8. Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 9. Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 10. Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 11. South Africa: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 12. South Africa: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 13. South Africa: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 14. South Africa: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 15. South Africa: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 16. South Africa: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 17. Saudi Arabia: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 18. Saudi Arabia: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 19. Saudi Arabia: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 20. Saudi Arabia: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 21. Saudi Arabia: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 22. Saudi Arabia: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 23. United Arab Emirates: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 24. United Arab Emirates: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 25. United Arab Emirates: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 26. United Arab Emirates: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 27. United Arab Emirates: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 28. United Arab Emirates: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 29. Rest of Middle East & Africa: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 30. Rest of Middle East & Africa: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 31. Rest of Middle East & Africa: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 32. Rest of Middle East & Africa: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 33. Rest of Middle East & Africa: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 34. Rest of Middle East & Africa: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
LIST OF FIGURES
Figure 1. Middle East & Africa Veterinary Vaccines Market Segmentation - Country
Figure 2. PEST Analysis
Figure 4. Middle East & Africa Veterinary Vaccines Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Middle East & Africa Veterinary Vaccines Market Revenue (US$ Million), 2024 - 2031
Figure 7. Middle East & Africa Veterinary Vaccines Market Share (%) - by Technology, 2024 and 2031
Figure 8. Live Attenuated Vaccines: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Inactivated Vaccines: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Recombinant Vaccines: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Toxoid Vaccines: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Others: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Middle East & Africa Veterinary Vaccines Market Share (%) - by Animal Type, 2024 and 2031
Figure 14. Companion: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Livestock and Poultry: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Middle East & Africa Veterinary Vaccines Market Share (%) - by Companion, 2024 and 2031
Figure 17. Dogs: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Cat: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Horses: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 20. Others: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Middle East & Africa Veterinary Vaccines Market Share (%) - by Livestock And Poultry, 2024 and 2031
Figure 22. Chicken: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. Cattle: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. Others: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Middle East & Africa Veterinary Vaccines Market Share (%) - by Route Of Administration, 2024 and 2031
Figure 26. Intramuscular: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Subcutaneous: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Others: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 29. Middle East & Africa Veterinary Vaccines Market Share (%) - by End User, 2024 and 2031
Figure 30. Veterinary Hospitals: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 31. Veterinary Clinics: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 32. Others: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 33. Middle East & Africa Veterinary Vaccines Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 34. South Africa: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 35. Saudi Arabia: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 36. United Arab Emirates: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 37. Rest of Middle East & Africa: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 1. Middle East & Africa Veterinary Vaccines Market Segmentation - Country
Figure 2. PEST Analysis
Figure 4. Middle East & Africa Veterinary Vaccines Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Middle East & Africa Veterinary Vaccines Market Revenue (US$ Million), 2024 - 2031
Figure 7. Middle East & Africa Veterinary Vaccines Market Share (%) - by Technology, 2024 and 2031
Figure 8. Live Attenuated Vaccines: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Inactivated Vaccines: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Recombinant Vaccines: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Toxoid Vaccines: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Others: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Middle East & Africa Veterinary Vaccines Market Share (%) - by Animal Type, 2024 and 2031
Figure 14. Companion: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Livestock and Poultry: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Middle East & Africa Veterinary Vaccines Market Share (%) - by Companion, 2024 and 2031
Figure 17. Dogs: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Cat: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Horses: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 20. Others: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Middle East & Africa Veterinary Vaccines Market Share (%) - by Livestock And Poultry, 2024 and 2031
Figure 22. Chicken: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. Cattle: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. Others: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Middle East & Africa Veterinary Vaccines Market Share (%) - by Route Of Administration, 2024 and 2031
Figure 26. Intramuscular: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Subcutaneous: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Others: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 29. Middle East & Africa Veterinary Vaccines Market Share (%) - by End User, 2024 and 2031
Figure 30. Veterinary Hospitals: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 31. Veterinary Clinics: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 32. Others: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 33. Middle East & Africa Veterinary Vaccines Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 34. South Africa: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 35. Saudi Arabia: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 36. United Arab Emirates: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 37. Rest of Middle East & Africa: Middle East & Africa Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
